Report

Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

See allHide authors and affiliations

Science  20 Aug 2004:
Vol. 305, Issue 5687, pp. 1163-1167
DOI: 10.1126/science.1101637

Log in to view full text

Log in through your institution

Log in through your institution

Subjects

Navigate This Article